Adoptive transfer of H-2-incompatible lymphokine-activated killer (LAK) cells: an approach for successful cancer immunotherapy free from graft-versus-host disease (GVHD) using murine models.

Toshitani, A; Taniguchi, K; Himeno, K; Kawano, Y; Nomoto, K

Toshitani, A; Taniguchi, K; Himeno, K; Kawano, Y; Nomoto, K.

Affiliation

Toshitani A; Department of Immunology, Kyushu University, Fukuoka, Japan.

Cell Immunol ; 115(2): 373-82, 1988 Sep.

Article in En | MEDLINE | ID: mdl-3409329

Subject(s)

H-2 Antigens/immunology; Killer Cells, Natural/transplantation; Lymphokines/pharmacology; Neoplasms, Experimental/therapy; Animals; Cytotoxicity, Immunologic; Disease Models, Animal; Graft vs Host Disease/immunology; Immunity, Cellular; Immunization, Passive; Immunotherapy; Killer Cells, Natural/immunology; Lymphocyte Activation; Mice; Neoplasm Metastasis; Spleen/pathology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / H-2 Antigens / Lymphokines / Neoplasms, Experimental Limits: Animals Language: En Journal: Cell Immunol Year: 1988 Document type: Article Affiliation country: Japan Country of publication: Netherlands

Search on Google

Add to My VHL

XML

PubMed Links